Cancer Immunology Immunotherapy · 2017 · 14 citations · 44 references
MedicineImmunologyOncologyImmunoregulationTumor ImmunologyTumor MicroenvironmentAntitumor T Cell ResponsesCancer GenomicsCancer ImmunosurveillanceCancer ImmunotherapyT Cell Responses To TumorsTumor ImmunopathologyHost Immune RejectionImmune RejectionImmune Rejection MechanismsImmunosuppressive FunctionTumor Immunogenomics
44
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Harriet M. Kluger, Margaret K. Callahan et al. · New England Journal of Medicine · 2013 · 4.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text